Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Anaplastic, Undifferentiated Thyroid Cancer”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Testing effectiveness (Phase 2)WithdrawnNCT02289144
What this trial is testing

Ceritinib in Mutation and Oncogene Directed Therapy in Thyroid Cancer

Who this might be right for
Metastatic Anaplastic Thyroid CancerLocally Advanced Anaplastic, Undifferentiated Thyroid Cancer
University of Texas Southwestern Medical Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06713057
What this trial is testing

Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer

Who this might be right for
Locally Advanced Thyroid Gland CarcinomaThyroid Cancer
West China Hospital 20
Early research (Phase 1)Study completedNCT00005647
What this trial is testing

SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck

Who this might be right for
Head and Neck Cancer
Case Comprehensive Cancer Center 12
Testing effectiveness (Phase 2)Ended earlyNCT00095693
What this trial is testing

Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer

Who this might be right for
Anaplastic Thyroid CancerInsular Thyroid CancerRecurrent Thyroid Cancer+4 more
National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Study completedNCT02688608
What this trial is testing

Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer

Who this might be right for
Anaplastic Thyroid Cancer
Saad A Khan 6
Testing effectiveness (Phase 2)Study completedNCT02114658
What this trial is testing

Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients

Who this might be right for
Thyroid Carcinoma
Bayer 18
Testing effectiveness (Phase 2)Study completedNCT04552769
What this trial is testing

Abemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer

Who this might be right for
Thyroid CancerAnaplastic Thyroid CancerUndifferentiated Thyroid Cancer
Stanford University 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT05119296
What this trial is testing

Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer

Who this might be right for
Thyroid Cancer
Stanford University 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT05453799
What this trial is testing

Vudalimab for the Treatment of Locally Advanced or Metastatic Anaplastic Thyroid Cancer or Hurthle Cell Thyroid Cancer

Who this might be right for
Locally Advanced Thyroid Gland Anaplastic CarcinomaMetastatic Thyroid Gland Anaplastic CarcinomaMetastatic Thyroid Gland Oncocytic Carcinoma
Northwestern University 54
Testing effectiveness (Phase 2)Study completedNCT00124527
What this trial is testing

Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid Cancer

Who this might be right for
Thyroid Cancer
Eisai Inc. 35
Testing effectiveness (Phase 2)Ended earlyNCT04644315
What this trial is testing

A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors

Who this might be right for
NeoplasmsColorectal NeoplasmsMelanoma+25 more
Hoffmann-La Roche 1
Testing effectiveness (Phase 2)Study completedNCT01164176
What this trial is testing

Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Yonsei University 40
Testing effectiveness (Phase 2)Study completedNCT00510640
What this trial is testing

Thyroid Cancer and Sunitinib

Who this might be right for
CancerThyroid Carcinoma
University Hospital, Bordeaux 71
Testing effectiveness (Phase 2)Ended earlyNCT03002623
What this trial is testing

CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer

Who this might be right for
Thyroid NeoplasmsPoorly Differentiated and Undifferentiated Thyroid CancerDifferentiated Thyroid Cancer
National Cancer Institute (NCI) 7
Testing effectiveness (Phase 2)Study completedNCT00389441
What this trial is testing

Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer

Who this might be right for
Thyroid Neoplasms
Pfizer 52
Testing effectiveness (Phase 2)WithdrawnNCT04731740
What this trial is testing

Pembrolizumab and Lenvatinib/Chemotherapy for Poorly Differentiated/Anaplastic Thyroid Cancer

Who this might be right for
Metastatic Thyroid Gland CarcinomaPoorly Differentiated Thyroid Gland CarcinomaThyroid Gland Anaplastic Carcinoma by AJCC V8 Stage
Saint Petersburg State University, Russia
Testing effectiveness (Phase 2)Study completedNCT00095836
What this trial is testing

Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy

Who this might be right for
Head and Neck Cancer
Massachusetts General Hospital 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT04171622
What this trial is testing

Lenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid Cancer

Who this might be right for
Metastatic Thyroid Gland CarcinomaPoorly Differentiated Thyroid Gland CarcinomaStage IVB Thyroid Gland Anaplastic Carcinoma AJCC v8+3 more
M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT02568267
What this trial is testing

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

Who this might be right for
Breast CancerCholangiocarcinomaColorectal Cancer+13 more
Hoffmann-La Roche 534
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69